SAN DIEGO, Feb. 5, 2019 /PRNewswire/ -- Shareholder
Rights Law Firm Johnson Fistel, LLP is investigating potential
claims against the following companies:
AbbVie Inc. (NYSE: ABBV) [click here to join this
action]
Macquarie Infrastructure Corporation
(NYSE:MIC) [click here to join this action]
OPKO
Health, Inc. (NASDAQ: OPK) [click here to join this
action]
Uxin Limited (NASDAQ: UXIN) [click here to
join this action]
AbbVie Inc. (Abbv)
Shareholder Rights Law Firm Johnson
Fistel, LLP is investigating potential violations of federal and
state laws by AbbVie Inc. (NYSE: ABBV) and certain of its
officers.
Last year a securities class action complaint was filed against
AbbVie. Throughout the class period, AbbVie allegedly made
materially false and/or misleading statements and/or failed to
disclose that: (1) AbbVie's strategy to increase the sales growth
of its blockbuster drug, HUMIRA, relied in part upon illegal
kickbacks and unlawful sales and marketing tactics; (2) such
practices would foreseeably lead to heightened scrutiny by State
governments and agencies; and (3) as a result, Defendants' public
statements were materially false and misleading at all relevant
times.
If you are a long-term shareholder of
AbbVie continuously holding shares
before,October 2013, you may have standing to hold AbbVie
harmless from the damage the officers and directors caused by
making them personally responsible. You may also be able to assist
in reforming the Company's corporate governance to prevent future
wrongdoing.
If you are interested in learning more about your legal
rights and remedies, please contact Jim
Baker (jimb@johnsonfistel.com) at 619-814-4471. If you
email, please include your phone number.
Additionally, you can [click here to join this action]. There
is no cost or obligation to you.
Macquarie Infrastructure Corporation (MIC)
Shareholder
Rights Law Firm Johnson Fistel, LLP is investigating potential
violations of federal and state laws by Macquarie Infrastructure
Corporation (NYSE:MIC) (Macquarie) and certain of its officers.
Last year a securities class action lawsuit was filed on behalf
of purchasers of the securities of Macquarie from February 22, 2016 through February 21, 2018, (the "Class Period").
According to the lawsuit, defendants during the Class Period made
materially false and/or misleading statements and/or failed to
disclose that: (1) Macquarie's International-Matex Tank Terminals'
("IMTT") performance and utilization were at risk of significant
decline due to ongoing industrywide changes in the market for heavy
residual oils, and in particular, declining demand and pricing for
No. 6 fuel oil; (2) IMTT relied significantly on demand for storage
of heavy residual fuel oils, including No. 6 fuel oil; and (3)
Macquarie needed to undertake significant capital expenditures to
repurpose IMTT storage tanks to accommodate alternative
products.
If you are a long-term shareholder of Macquarie
continuously holding shares before February
2016, you may have standing to hold Macquarie harmless
from the alleged harm caused by the officers and directors of the
Company by making them personally responsible. You may also be able
to assist in reforming the Company's corporate governance to
prevent future wrongdoing.
If you are interested in learning more about your legal
rights and remedies, please contact Jim
Baker (jimb@johnsonfistel.com) at 619-814-4471. If you
email, please include your phone number.
Additionally, you can [click here to join this action]. There
is no cost or obligation to you.
OPKO Health, Inc. (OPK)
Shareholder Rights Law Firm Johnson Fistel, LLP is investigating
potential violations of federal and state laws by OPKO Health, Inc.
(NASDAQ: OPK) (OPKO) and certain of its officers.
Last year a securities class action lawsuit was filed on behalf
of purchasers of the securities of OPKO from September 26, 2013 through September 7, 2018, (the "Class Period").
According to the lawsuit, defendants made false and/or misleading
statements and/or failed to disclose that: (1) OPKO and its
Chairman and Chief Executive Officer, Phillip Frost, were engaged in a pump-and-dump
scheme with several other individuals and companies in their
investments in several penny stocks; (2) this illicit scheme would
result in governmental scrutiny including from the SEC; and (3) as
a result, defendants' statements about OPKO's business, operations
and prospects were materially false and misleading and/or lacked a
reasonable basis at all relevant times.
If you are a long-term shareholder of
OPKO continuously holding shares before
September 2013, you may have
standing to hold OPKO harmless from the alleged harm caused by the
officers and directors of the Company by making them personally
responsible. You may also be able to assist in reforming the
Company's corporate governance to prevent future wrongdoing.
If you are interested in learning more about your legal
rights and remedies, please contact Jim
Baker (jimb@johnsonfistel.com) at 619-814-4471. If you
email, please include your phone number.
Additionally, you can [click here to join this action] .
There is no cost or obligation to you.
Uxin Limited (UXIN)
Shareholder Rights Law Firm
Johnson Fistel, LLP is investigating potential violations of
federal securities laws by Uxin Limited (NASDAQ: UXIN) (Uxin) and
certain of its officers.
On or about June 27, 2018, Uxin
sold 25 million shares of stock in its initial public stock
offering (the "IPO"), at $9 a share
raising $225,200,000 in new
capital. However, since the IPO, Uxin stock has plunged, on
February 1, 2019, the stock closed at
$3.44.
Specifically, Johnson Fistel's
investigation seeks to determine whether the Company's filings with
the U.S. Securities and Exchange Commission in connection with its
June 2018 initial public stock
offering (the "IPO") contained untrue statements of material facts
or omitted to state other facts necessary to make the statements
made therein not misleading concerning the Company's business, and
operations.
If you have information that could assist in this
investigation, or if you are a Uxin shareholder and
are interested in learning more about the investigation or your
legal rights and remedies, please contact Jim Baker (jimb@johnsonfistel.com) at
619-814-4471. If emailing, please include a phone number.
Additionally, you can [click here to join this
action]. There is no cost or obligation to you.
About Johnson Fistel,
LLP:
Johnson Fistel, LLP is a
nationally recognized shareholder rights law firm with offices in
California, New York, and Georgia. The firm represents individual and
institutional investors in shareholder derivative and securities
class action lawsuits. For more information about the firm and its
attorneys, please visit http://www.johnsonfistel.com. Attorney
advertising. Past results do not guarantee future outcomes.
Contact:
Johnson Fistel, LLP
Jim Baker, 619-814-4471
jimb@johnsonfistel.com
View original
content:http://www.prnewswire.com/news-releases/johnson-fistel-llp-announces-investigations-of-abbvie-inc-macquarie-infrastructure-corporation-opko-health-inc-and-uxin-limited-investors-encouraged-to-contact-firm-300789588.html
SOURCE Johnson Fistel, LLP